You Searched For: OZ+BIOSCIENCES
164 results were found
Layout 1
/www.boreal.com/images/Dermestid_Beetles.pdf
Layout 1 Conditions for Customer Ownership We hold permits allowing us to transport these organisms. To access permit conditions click here. Never purchase living specimens without having a disposition strategy in place. There are currently no USD...
~~29188433AA Production of recombinant monoclonal an~~
/m-si.vwr.com/sl_SI/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
~~29188433AA Production of recombinant monoclonal an~~
/m-dk.vwr.com/da_DK/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
~~29188433AA Production of recombinant monoclonal an~~
/m-nl.vwr.com/nl_NL/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
~~29188433AA Production of recombinant monoclonal an~~
/m-no.vwr.com/no_NO/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
~~29188433AA Production of recombinant monoclonal an~~
/m-pl.vwr.com/pl_PL/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
~~29188433AA Production of recombinant monoclonal an~~
/m-in.vwr.com/en_IN/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
~~29188433AA Production of recombinant monoclonal an~~
/m-de.vwr.com/de_DE/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
Annelids
/www.boreal.com/images/Annelids.pdf
Annelids Conditions for Customer Ownership (per USDA Permits) We hold permits allowing us to transport these organisms. To access permit conditions click here. Never purchase living specimens without having a disposition strategy in place. •There ...
~~29188433AA Production of recombinant monoclonal an~~
/m-it.vwr.com/it_IT/images/29188433AA_Production_of_recombinant_monoclonal_an.pdf
1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...
CLS-AN-464-A4-DL
/m-dk.vwr.com/da_DK/images/CLS-AN-464-A4-DL.pdf
A Novel Method for Generating Single Intestinal Organoids for High Throughput Screening Application Note Hilary Sherman and Hannah J. Gitschier M.S. Corning Incorporated Life Sciences Kennebunk ME USA Introduction For successful drug development t...
CLS-AN-464-A4-DL
/m-ni.vwr.com/en_NI/images/CLS-AN-464-A4-DL.pdf
A Novel Method for Generating Single Intestinal Organoids for High Throughput Screening Application Note Hilary Sherman and Hannah J. Gitschier M.S. Corning Incorporated Life Sciences Kennebunk ME USA Introduction For successful drug development t...
~~29105173AC HyCell TransFx media~~
/m-de.vwr.com/de_DE/images/29105173AC_HyCell_TransFx_media.pdf
GE Healthcare Enhance transfection increase cell viability and optimize productivity in HEK 293 and CHO cells HyCell™ TransFx media Simplified transient transfection with HyCell TransFx media HyClone™ HyCell TransFx-H and TransFx-C media are optim...
~~29105173AC HyCell TransFx media~~
/m-nl.vwr.com/nl_NL/images/29105173AC_HyCell_TransFx_media.pdf
GE Healthcare Enhance transfection increase cell viability and optimize productivity in HEK 293 and CHO cells HyCell™ TransFx media Simplified transient transfection with HyCell TransFx media HyClone™ HyCell TransFx-H and TransFx-C media are optim...
~~29105173AC HyCell TransFx media~~
/m-cz.vwr.com/cs_CZ/images/29105173AC_HyCell_TransFx_media.pdf
GE Healthcare Enhance transfection increase cell viability and optimize productivity in HEK 293 and CHO cells HyCell™ TransFx media Simplified transient transfection with HyCell TransFx media HyClone™ HyCell TransFx-H and TransFx-C media are optim...
~~29105173AC HyCell TransFx media~~
/m-pt.vwr.com/pt_PT/images/29105173AC_HyCell_TransFx_media.pdf
GE Healthcare Enhance transfection increase cell viability and optimize productivity in HEK 293 and CHO cells HyCell™ TransFx media Simplified transient transfection with HyCell TransFx media HyClone™ HyCell TransFx-H and TransFx-C media are optim...
1 - 16 of 164